Shingrix Vaccine Cuts Risk of Herpes Zoster Ophthalmicus, Heart Attack, and Stroke in Adults 50+: Study
A new study published in the journal of Clinical Infectious Diseases showed that in addition to reducing the incidence of herpes zoster ophthalmicus (HZO) by 72.9%, the recombinant herpes zoster vaccine (Shingrix) was associated with a decreased risk of hospitalization for acute myocardial infarction (MI) and stroke in patients 50 years of age and older. […]